cDC2s prime CD4+ T cell-mediated anti-tumour immunity when released from suppression by tumour regulatory T cells [41] and stimulation with type 1 interferons promotes cDC1-like cross-presentation to CD8+ T cells from cDC2s [42]. Here, CD8A is linked to neoplasm.